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Identity 
Phylum 
Urinary 
system:Kidney:Adult:Oncocytoma/oncocytosis 
Classification 
Note 
Renal Oncocytoma is a benign renal epithelial 
neoplasm that comprises approximately 5-9% of 
renal tubular epithelial tumors. 
Clinics and pathology 
Note 
The first case of renal oncocytoma was reported by 
Zippel in 1942. Since then this tumor have been 
described as proximal tubular adenoma with 
oncocytic features and later oncocytoma became the 
generally accepted term. 
Embryonic origin 
Many investigators have suggested that these tumors 
originate from intercalated cells of the collecting 
system. 
Etiology 
Renal oncocytomas can present in familial or 
sporadic forms. Oncocytomas may be seen in 
patients with Birt-Hogg-Dube syndrome (BHD, who 
carry germline mutations in the folliculin gene 
(FLCN). However, sporadic cases are much more 
common and have an unknown etiology. 
Epidemiology 
Renal oncocytomas account for about 5-9% of all 
renal tumors and occur across a broad age range, 
peaking in the seventh decade. There is a male 
predominance (2:1) and tumors are frequently small 
and found incidentally. A rare association between 
oncocytoma and angiomyolipoma or tuberous 
sclerosis has been reported.. 
Pathology 
Macroscopically, renal oncocytomas are well-
circumscribed, slightly lobulated solid tumors with 
generally mahogany brown or dark red cut surface. 
The tumors are typically solitary, but can be 
multifocal or bilateral. A central scar is frequently 
observed. Some cases show involvement of the 
perinephric fat or rarely the renal vein with no 
change in prognosis. Microscopically, the tumor is 
composed of nests and tubular structures made up 
from oncocytic cells, and is frequently associated 
with fibrous or edematous stroma. The tumor cells 
are large round eosinophilic cells with granular 
cytoplasm that is packed with mitochondria. Nuclei 
are round and monomorphic and contain small 
nucleoli. Tumor cells around the central scar are 
small with scant cytoplasm. Bizarre cells with 
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pleomorphic nuclei may be present in some tumors 
and have no affect on outcome. Mitoses and necrosis 
are not seen. Tumor cells are typically 
immunoreactive for KIT, S100A (multifocal), and 
HNF1beta, and are negative for CD10, AMACR and 
vimentin. CK7 is usually negative or patchy positive 
with immunoreactivityini single scattered cells; this 
is in contrast to chromophobe renal cell carcinoma 
which shows diffuse membranous positivity. 
Rare cases that show multiple oncocytic tumors can 
be referred to as oncocytosis. Oncocytosis, as well as 
hybrid oncocytic tumors may occur sporadically or 
in association with Birt-Hogg-Dubé syndrome. . 
 
Figure 1A:  Oncocytoma is a benign renal epithelial neoplasm. Oncocytomas contain small oncocytic cells with 
round, regular nuclei that sometimes contain a small nucleolus. Architecturally the tumors are solid, nested or 
tubular, and are frequently associated with edematous stroma. 
 
Figure 1B:  Occasionally oncocytomas extend into perinephric adipose tissue; this findings has no affect on 
clinical outcome (i.e., the tumor is still benign). 
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Figure 1C:  A small subset of oncocytomas demonstrate nuclear atypia and/or multinucleation. Some think this 
is due to degenerative change. Regardless, these nuclear features do not affect clinical outcome (i.e., the tumor is 
still benign). 
Treatment 
Most patients with RO are treated with nephrectomy. 
Nephrectomy (radical or partial). Enucleation, 
wedge resection or ablation may also be considered 
for treatment options but are less common. 
Prognosis 
Oncocytomas behave in a benign fashion. Atypical 
pathologic features, such as nuclear pleomorphism, 
perinephric fat involvement and extension into renal 
vein branches do not influence prognosis. 
Cytogenetics 
Note 
Oncocytomas frequently exhibit losses of 
chromosome 1/1p-, chromosome 14 and/or a sex 
chromosome. Structural rearrangements of 11q13 
have been reported, with t(5;11) and t(9;11) 
representing the most common translocations. A 
t(6;9)(p21;p23) has been reported in three cases of 
oncocytoma (Balzarini et al., 1999; Hudacko et al., 
2011). A subset of oncocytomas exhibit non-
recurrent numerical or structural abnormalities A 
normal karyotype is also frequently observed. 
 
One of the diagnostic pitfalls in renal epithelial 
tumors is distinguishing between benign RO from 
the eosinophillic variant of chromophobe carcinoma. 
Many studies have reported that chromophobe RCC 
shows complex simultaneous losses of 
chromosomes 1, 2, 6, 10, 13, 17, and 21. Although 
occasional losses of all these chromosomes have 
been reported in RO, the simultaneous loss of all 
these chromosomes has not been seen in 
oncocytomas. 
Genes involved and 
proteins 
Note 
Mitochondrial DNA mutations that disrupt 
components of complex I in the electron transport 
chain can be found in bilateral and multifocal 
oncocytomas (Lang et al., 2015). 
FLCN (folliculin gene) 
Location 
17p11.2 
Note 
Germline mutations in FLCN cause Birt-Hogg-Dubé 
syndrome, an inherited disorder characterized by 
follicular hamartomas, renal tumors, pulmonary 
cysts, and spontaneous pneumothorax. Hybrid 
oncocytic/chromophobe tumors and chromophobe 
renal cell carcinomas are the most common renal 
tumors in Birt-Hogg-Dubé syndrome, but 
oncocytomas may be seen in a subset of cases. The 
renal tumors are typically bilateral and multifocal. 
Protein 
Folliculin is a putative tumor suppressor that plays a 
role in the regulation of energy homeostasis and 
AMPK and CC: TXT: mTOR ID: 40639> signaling. 
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